Methods And Compositions Relating To Hdac 4 And 5 Regulation Of Cardiac Gene Expression

Abstract

The present invention relates to cardiac hypertrophy. More particularly, the present invention defines the molecular events linking calcium stimulation to cardiac hypertrophy. More specifically, the present invention shows that Ca<SUP>2+</SUP> stimulation of the hypertrophic response is mediated through an HDAC 4 and 5 interaction with MEF2, and that phosphorylation of HDACs results in loss of HDAC-mediated repression of MEF2 hypertrophic action. Thus, the present invention provides methods and compositions of treating cardiac hypertrophy, as well as methods and compositions for identifying subjects at risk for cardiac hypertrophy. Further provided are methods for the detection of compounds having therapeutic activity toward cardiac hypertrophy.


Claims
Owners (US)

Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Sep 2, 2008
  • Application: Aug 8, 2003
    US US 63740303 A
  • Priority: Aug 8, 2003
    US US 63740303 A
  • Priority: Aug 21, 2000
    US US 64320600 A
  • Priority: Aug 20, 1999
    US US 15004899 P

Download Citation


Sign in to the Lens

Feedback